(Q45384951)

English

Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG.

scientific article published on 8 September 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

diffuse midline glioma

0 references

0 references

1 reference

based on heuristic

inferred from title

6

object named as

Eric Bouffet

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

object named as

Ute Bartels

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cynthia Hawkins

2

object named as

Cynthia Hawkins

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Gilbert Vézina

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Larry Kun

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Mark Souweidane

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

8 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

119-125

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Diffuse brainstem glioma in children: critical review of clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Trends in reported incidence of primary malignant brain tumors in children in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherap

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Permanent I-125 brain stem implants in children

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Radiation associated brainstem injury

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Chemotherapy for brain stem gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of everolimus in pediatric patients with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-011-0704-4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Dimensions Publication ID

0 references

release_jqrkt2rpqneyxodtbteirqwtmu

1 reference

https://api.fatcat.wiki/v0/release/jqrkt2rpqneyxodtbteirqwtmu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45384951&oldid=2207238100"